Urine drug screens are often confusing if you don’t interpret them on a regular basis. I think a big reason for confusion is a lack of education on what these tools can do and what they look at. I would definitely classify myself as needing to learn more about...
In a previous post, I dug a little into pharmacodynamics. In this post I am going to be explaining pharmacokinetics. In pharmacy and the medical profession we tend to use really big, fancy words to intimidate people, not sure why, but we do. Remember that:...
I appreciate the fantastic guest post from Amanuel Tseggai, Pharm.D., BCPS! There are plenty of clinical considerations when it comes to gabapentin. Here’s a scenario of using gabapentin in chronic kidney disease. A 42 year old African American man with a history of...
Two very common terms in pharmacology and the pharmacy world in general are pharmacodynamics and pharmacokinetics. The best way I have been taught these terms is by the following: Pharmacodynamics – what the drug does to the body Pharmacokinetics – what...
There’s a lot that goes into selecting beta blocking agents. In pharmacy school we’ve learned that beta blockers fall into two major categories with respect to their pharmacotherapeutic properties: Selective (B1) and nonselective (B1,B2) beta antagonists....
KL is a 79 year old male with a history of Parkinson’s disease. About 2 weeks ago, he had been having worsening symptoms of rigidity and his wife is concerned with this newer development. At that time, his Sinemet dosing was increased from 25/100 TID to 50/200 TID....
